Likewise, improvement in the iron-related parameters, such as mean Hb, serum iron, and mean corpuscular volume, in RA patients with anemia (mean Hb: 11.3 g/dL) has been reported after tocilizumab treatment [13, 14]. The gene discussed is GSTM1; the disease is anemia (phenotype).